Greenland Mines Ltd (NASDAQ: GRML) announced that independent consultant SLR Consulting (Canada) Ltd. has completed the first U.S. Securities and Exchange Commission S-K 1300-compliant Technical Report Summary for the Skaergaard project in southeast Greenland. The report features an updated 2026 Mineral Resource Estimate effective July 3, 2026, which showed a 31% increase in indicated contained palladium equivalent (“PdEq”) metal to 15.0 million ounces, a 36% increase in indicated grade to 3.04 g/t PdEq, and a 24% increase in inferred contained PdEq metal to 17.49 million ounces compared to the project’s 2022 resource estimate.
The upgraded resource reflects improved geological modeling and updated metal price assumptions, including gold at $3,500 per ounce. The company stated that the report provides the regulatory foundation to advance toward an Initial Assessment under S-K 1300. Greenland Mines also noted that its 2026 field program is underway with drilling, bulk sampling, engineering, environmental and geotechnical work designed to support evaluation of both open-pit and underground mining scenarios at the Skaergaard project.
This news is significant because Skaergaard is one of the world’s largest undeveloped palladium resources. The substantial increase in resource estimates strengthens the project's economic viability and could position Greenland Mines as a key supplier of critical metals, including palladium, which is essential for catalytic converters in vehicles and various industrial applications. The updated resource estimate also enhances the company’s ability to attract financing and partnerships for development.
For investors, the upgraded resource may signal potential upside in the company's valuation. The S-K 1300 compliance adds credibility to the resource estimate, which is a requirement for SEC reporting and may facilitate listing on major exchanges. The ongoing field program will provide further data to advance the project towards a preliminary economic assessment, which could provide more clarity on production timelines and costs.
Greenland Mines operates with two divisions: mining, focused on exploration and development of the Skaergaard project and the Sarfartoq rare earths project; and biotech, including Klotho’s KLTO‑202 primary indication for ALS. The company’s strategy centers on building a multi-asset platform with exposure to rare earth magnet materials, precious metals, and midstream processing opportunities, while advancing its North Atlantic Critical Metals Corridor vision.
For more information, visit the company’s newsroom at https://ibn.fm/GRML.
